Glaxosmithkline Phar - Quarterly Results
22nd Jul 2019

The Revenue for the quarter ended  June 2019 of Rs. 7880.20 millions grew by 7.12 % from Rs. 7356.50 millions.The company has announced a 28.07% increase in its profits to Rs . 1134.60  millions for the  quarter ended June 2019 compared to Rs. 885.90 millions in the corresponding quarter in the previous year.Operating profit for the quarter ended June 2019 rose to 1960.20 millions as compared to 1581.50 millions of corresponding quarter ended June 2018.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  201906 201806 % Var 201906 201806 % Var 201903 201803 % Var
Sales 7880.20 7356.50 7.12 7880.20 7356.50 7.12 31285.30 28958.80 8.03
Other Income 305.40 177.80 71.77 305.40 177.80 71.77 1014.80 535.20 89.61
PBIDT 1960.20 1581.50 23.95 1960.20 1581.50 23.95 7079.60 5619.60 25.98
Interest 9.30 2.00 365.00 9.30 2.00 365.00 5.50 1.90 189.47
PBDT 1950.90 1496.70 30.35 1950.90 1496.70 30.35 7123.00 5795.70 22.90
Depreciation 190.60 113.60 67.78 190.60 113.60 67.78 485.90 379.90 27.90
PBT 1760.30 1383.10 27.27 1760.30 1383.10 27.27 6637.10 5415.80 22.55
TAX 625.70 497.20 25.84 625.70 497.20 25.84 2383.50 1896.00 25.71
Deferred Tax 61.60 50.20 22.71 61.60 50.20 22.71 455.30 -147.40 -408.89
PAT 1134.60 885.90 28.07 1134.60 885.90 28.07 4253.60 3519.80 20.85
Equity 1694.10 847.00 100.01 1694.10 847.00 100.01 1694.10 847.00 100.01
PBIDTM(%) 24.88 21.50 15.71 24.88 21.50 15.71 22.63 19.41 16.61